Status:
COMPLETED
SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)
Lead Sponsor:
Antonio Secchi
Conditions:
Kidney Transplant
Pancreatic Transplat
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.
Eligibility Criteria
Inclusion
- Inclusion Criteria Cohort 1:
- Adult patients (age ≥ 18 years),
- Kidney or pancreas or pancreatic islets transplantation
- Transplanted patients (period: 01.01.2020 to 30.06.2020)
- Informed Consent signed
- Inclusion Criteria Cohort 2:
- Adult patients (age ≥ 18 years),
- Kidney or pancreas or pancreatic islets transplantation
- transplanted patients in follow-up since 01.01.2020 or trasplanted patients after 30.06.2020.
- Informed Consent signed
- Exclusion Criteria both Cohort (1\&2):
- Symptomatology such as fever\> 37.5, and / or cough and / or respiratory distress and / or diarrhea / vomiting in 14 days prior to collection of blood sample
Exclusion
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT04487197
Start Date
July 15 2020
End Date
January 15 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132